Scribe Therapeutics
Addison Wright has two years of professional experience, beginning in 2018. From 2018 to 2019, they worked as a Postdoctoral Researcher at the Howard Hughes Medical Institute. In 2019, they began working as a Scientist at Scribe Therapeutics.
Addison Wright obtained a Bachelor's degree in Biochemistry and Molecular Biology from The University of Georgia between 2009 and 2013. Subsequently, they completed a Doctor of Philosophy - PhD in Cell/Cellular and Molecular Biology from the University of California, Berkeley in 2018.
Scribe Therapeutics
1 followers
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.